Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (8441)
All Articles published online
|
Publishing Process of This Article
|
Aug 28, 2014 (publication date) through Apr 25, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Liu CJ, Chang J, Lee PH, Lin DY, Wu CC, Jeng LB, Lin YJ, Mok KT, Lee WC, Yeh HZ, Ho MC, Yang SS, Yang MD, Yu MC, Hu RH, Peng CY, Lai KL, Chang SSC, Chen PJ. Adjuvant heparanase inhibitor PI-88 therapy for hepatocellular carcinoma recurrence. World J Gastroenterol 2014; 20(32): 11384-11393 [PMID: 25170226 DOI: 10.3748/wjg.v20.i32.11384] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v20/i32/11384.htm |
| Number | Citing Articles |
| 1 |
Mohit Chhabra, Vito Ferro. Heparanase. Advances in Experimental Medicine and Biology 2020; 1221: 473 doi: 10.1007/978-3-030-34521-1_19
|
| 2 |
Andrew W. Holle, Jennifer L. Young, Krystyn J. Van Vliet, Roger D. Kamm, Dennis Discher, Paul Janmey, Joachim P. Spatz, Taher Saif. Cell–Extracellular Matrix Mechanobiology: Forceful Tools and Emerging Needs for Basic and Translational Research. Nano Letters 2018; 18(1): 1 doi: 10.1021/acs.nanolett.7b04982
|
| 3 |
Xiaoyang Dai, Juan Yan, Xuhong Fu, Qiuming Pan, Danni Sun, Yuan Xu, Jiang Wang, Litong Nie, Linjiang Tong, Aijun Shen, Mingyue Zheng, Min Huang, Minjia Tan, Hong Liu, Xun Huang, Jian Ding, Meiyu Geng. Aspirin Inhibits Cancer Metastasis and Angiogenesis via Targeting Heparanase. Clinical Cancer Research 2017; 23(20): 6267 doi: 10.1158/1078-0432.CCR-17-0242
|
| 4 |
Israel Vlodavsky, Yasmin Kayal, Maram Hilwi, Soaad Soboh, Ralph D. Sanderson, Neta Ilan. Heparanase—A single protein with multiple enzymatic and nonenzymatic functions. Proteoglycan Research 2023; 1(3) doi: 10.1002/pgr2.6
|
| 5 |
Rong-rui Wei, Dan-ni Sun, Hong Yang, Juan Yan, Xiong Zhang, Xing-ling Zheng, Xu-hong Fu, Mei-yu Geng, Xun Huang, Jian Ding. CTC clusters induced by heparanase enhance breast cancer metastasis. Acta Pharmacologica Sinica 2018; 39(8): 1326 doi: 10.1038/aps.2017.189
|
| 6 |
Vikrant Rai, Joe Abdo, Abdullah N. Alsuwaidan, Swati Agrawal, Poonam Sharma, Devendra K. Agrawal. Cellular and molecular targets for the immunotherapy of hepatocellular carcinoma. Molecular and Cellular Biochemistry 2018; 437(1-2): 13 doi: 10.1007/s11010-017-3092-z
|
| 7 |
Sameer Ullah Khan, Kaneez Fatima, Fayaz Malik, Halime Kalkavan, Abubakar Wani. Cancer metastasis: Molecular mechanisms and clinical perspectives. Pharmacology & Therapeutics 2023; 250: 108522 doi: 10.1016/j.pharmthera.2023.108522
|
| 8 |
Tadas Rimkus, Richard Carpenter, Shadi Qasem, Michael Chan, Hui-Wen Lo. Targeting the Sonic Hedgehog Signaling Pathway: Review of Smoothened and GLI Inhibitors. Cancers 2016; 8(2): 22 doi: 10.3390/cancers8020022
|
| 9 |
Yan Zhang, Fengshan Wang. Carbohydrate drugs: current status and development prospect. Drug Discoveries & Therapeutics 2015; 9(2): 79 doi: 10.5582/ddt.2015.01028
|
| 10 |
Shadi Hamoud. Non-alcoholic Fatty Liver Disease - New Insight and Glance Into Disease Pathogenesis. 2023; doi: 10.5772/intechopen.107530
|
| 11 |
J.-P. Li, M. Kusche-Gullberg. . International Review of Cell and Molecular Biology 2016; 325: 215 doi: 10.1016/bs.ircmb.2016.02.009
|
| 12 |
Krishnath M. Jayatilleke, Mark D. Hulett. Heparanase and the hallmarks of cancer. Journal of Translational Medicine 2020; 18(1) doi: 10.1186/s12967-020-02624-1
|
| 13 |
Olga Kantor, Marshall S. Baker. Gastrointestinal Malignancies. Cancer Treatment and Research 2016; : 165 doi: 10.1007/978-3-319-34244-3_8
|
| 14 |
Femke Heindryckx, Pär Gerwins. Targeting the tumor stroma in hepatocellular carcinoma. World Journal of Hepatology 2015; 7(2): 165-176 doi: 10.4254/wjh.v7.i2.165
|
| 15 |
Holly E. Barker, James T. E. Paget, Aadil A. Khan, Kevin J. Harrington. The tumour microenvironment after radiotherapy: mechanisms of resistance and recurrence. Nature Reviews Cancer 2015; 15(7): 409 doi: 10.1038/nrc3958
|
| 16 |
Valentina Masola, Gianluigi Zaza, Giovanni Gambaro, Marco Franchi, Maurizio Onisto. Role of heparanase in tumor progression: Molecular aspects and therapeutic options. Seminars in Cancer Biology 2020; 62: 86 doi: 10.1016/j.semcancer.2019.07.014
|
| 17 |
Darpan Saraswat, R. Ross Welliver, Roopa Ravichandar, Ajai Tripathi, Jessie J. Polanco, Jacqueline Broome, Edward Hurley, Ranjan Dutta, M. Laura Feltri, Fraser J. Sim. Heparanome-Mediated Rescue of Oligodendrocyte Progenitor Quiescence following Inflammatory Demyelination. The Journal of Neuroscience 2021; 41(10): 2245 doi: 10.1523/JNEUROSCI.0580-20.2021
|
| 18 |
Felipe C. O. B. Teixeira, Martin Götte. Heparanase. Advances in Experimental Medicine and Biology 2020; 1221: 97 doi: 10.1007/978-3-030-34521-1_4
|
| 19 |
Qi-Wei Li, Gan-Lin Zhang, Cai-Xia Hao, Yun-Fei Ma, Xu Sun, Yi Zhang, Ke-Xin Cao, Bing-Xue Li, Guo-Wang Yang, Xiao-Min Wang. SANT, a novel Chinese herbal monomer combination, decreasing tumor growth and angiogenesis via modulating autophagy in heparanase overexpressed triple-negative breast cancer. Journal of Ethnopharmacology 2021; 266: 113430 doi: 10.1016/j.jep.2020.113430
|
| 20 |
Paul N. Handley, Anthony Carroll, Vito Ferro. New structural insights into the oligosaccharide phosphate fraction of Pichia ( Hansenula ) holstii NRRL Y2448 phosphomannan. Carbohydrate Research 2017; : 68 doi: 10.1016/j.carres.2017.05.008
|
| 21 |
Maria Francesca Secchi, Marika Crescenzi, Valentina Masola, Francesco Paolo Russo, Annarosa Floreani, Maurizio Onisto. Heparanase and macrophage interplay in the onset of liver fibrosis. Scientific Reports 2017; 7(1) doi: 10.1038/s41598-017-14946-0
|
| 22 |
Li Li, Uri Barash, Neta Ilan, Malik Farhoud, Xiao Zhang, Israel Vlodavsky, Jin-Ping Li. A New Synthesized Dicarboxylated Oxy-Heparin Efficiently Attenuates Tumor Growth and Metastasis. Cells 2024; 13(3): 211 doi: 10.3390/cells13030211
|
| 23 |
Andrew W. Holle, Jennifer L. Young, Joachim P. Spatz. In vitro cancer cell–ECM interactions inform in vivo cancer treatment. Advanced Drug Delivery Reviews 2016; 97: 270 doi: 10.1016/j.addr.2015.10.007
|
| 24 |
Rio S. Boothello, Nirmita J. Patel, Chetna Sharon, Elsamani I. Abdelfadiel, Shravan Morla, Donald F. Brophy, H. Robert Lippman, Umesh R. Desai, Bhaumik B. Patel. A Unique Nonsaccharide Mimetic of Heparin Hexasaccharide Inhibits Colon Cancer Stem Cells via p38 MAP Kinase Activation. Molecular Cancer Therapeutics 2019; 18(1): 51 doi: 10.1158/1535-7163.MCT-18-0104
|
| 25 |
Liang Wu, Gideon J. Davies. Heparanase. Advances in Experimental Medicine and Biology 2020; 1221: 139 doi: 10.1007/978-3-030-34521-1_5
|
| 26 |
Cinzia Lanzi, Giuliana Cassinelli. Heparan Sulfate Mimetics in Cancer Therapy: The Challenge to Define Structural Determinants and the Relevance of Targets for Optimal Activity. Molecules 2018; 23(11): 2915 doi: 10.3390/molecules23112915
|
| 27 |
Jia Zhang, Kai Li, Hao‐Ran Sun, Shao‐Kun Sun, Ya‐Ting Zhu, Yu‐Ting Ge, Yu‐Xuan Wu, Qin‐Yao Zhou, Guan‐Ting Li, Xiao‐Ai Chang, Peng Sun, Ying Ding, Xiao Han. The heparan sulfate mimetic Muparfostat aggravates steatohepatitis in obese mice due to its binding affinity to lipoprotein lipase. British Journal of Pharmacology 2023; 180(14): 1803 doi: 10.1111/bph.16047
|
| 28 |
Antonio Gnoni, Daniele Santini, Mario Scartozzi, Antonio Russo, Antonella Licchetta, Vincenzo Palmieri, Luigi Lupo, Luca Faloppi, Giuseppe Palasciano, Vincenzo Memeo, Gioacchino Angarano, Oronzo Brunetti, Attilio Guarini, Salvatore Pisconti, Vito Lorusso, Nicola Silvestris. Hepatocellular carcinoma treatment over sorafenib: epigenetics, microRNAs and microenvironment. Is there a light at the end of the tunnel?. Expert Opinion on Therapeutic Targets 2015; 19(12): 1623 doi: 10.1517/14728222.2015.1071354
|
| 29 |
Ryan J. Weiss, Jeffrey D. Esko, Yitzhak Tor. Targeting heparin and heparan sulfate protein interactions. Organic & Biomolecular Chemistry 2017; 15(27): 5656 doi: 10.1039/C7OB01058C
|
| 30 |
Shi-Dong Lu, Lin Li, Xin-Min Liang, Wu Chen, Fu-Li Chen, Lang-Lin Fan, Bhavesh K. Ahir, Wan-Guang Zhang, Jian-Hong Zhong. Updates and advancements in the management of hepatocellular carcinoma patients after hepatectomy. Expert Review of Gastroenterology & Hepatology 2019; 13(11): 1077 doi: 10.1080/17474124.2019.1684898
|
| 31 |
Zaid Abassi, M. S. Goligorsky. Heparanase. Advances in Experimental Medicine and Biology 2020; 1221: 685 doi: 10.1007/978-3-030-34521-1_28
|
| 32 |
Alexia Abecassis, Esther Hermano, Kim Sheva, Ariel M. Rubinstein, Michael Elkin, Amichay Meirovitz. Radiation-Induced Nephropathy in the Murine Model Is Ameliorated by Targeting Heparanase. Biomedicines 2023; 11(3): 710 doi: 10.3390/biomedicines11030710
|
| 33 |
Alyce J. Mayfosh, Nikola Baschuk, Mark D. Hulett. Leukocyte Heparanase: A Double-Edged Sword in Tumor Progression. Frontiers in Oncology 2019; 9 doi: 10.3389/fonc.2019.00331
|
| 34 |
Emilia Hardak, Eli Peled, Yonatan Crispel, Shourouk Ghanem, Judith Attias, Keren Asayag, Inna Kogan, Yona Nadir. Heparan sulfate chains contribute to the anticoagulant milieu in malignant pleural effusion. Thorax 2020; 75(2): 143 doi: 10.1136/thoraxjnl-2018-212964
|
| 35 |
Zhi-Ming Zeng, Ning Mo, Jie Zeng, Fu-Chao Ma, Yan-Feng Jiang, Hua-Sheng Huang, Xi-Wen Liao, Guang-Zhi Zhu, Jie Ma, Tao Peng. Advances in postoperative adjuvant therapy for primary liver cancer. World Journal of Gastrointestinal Oncology 2022; 14(9): 1604-1621 doi: 10.4251/wjgo.v14.i9.1604
|
| 36 |
Jiang Chen, Renan Jin, Jie Zhao, Jinghua Liu, Hanning Ying, Han Yan, Senjun Zhou, Yuelong Liang, Diyu Huang, Xiao Liang, Hong Yu, Hui Lin, Xiujun Cai. Potential molecular, cellular and microenvironmental mechanism of sorafenib resistance in hepatocellular carcinoma. Cancer Letters 2015; 367(1): 1 doi: 10.1016/j.canlet.2015.06.019
|
| 37 |
Biagio Ricciuti, Jennifer Foglietta, Vanessa Bianconi, Amirhossein Sahebkar, Matteo Pirro. Enzymes involved in tumor-driven angiogenesis: A valuable target for anticancer therapy. Seminars in Cancer Biology 2019; 56: 87 doi: 10.1016/j.semcancer.2017.11.005
|
| 38 |
Carla Cristina Lopes, Jessica Oyie Sousa Onyeisi, Maria Cecilia Zorél Meneghetti, Carina Mucciolo Melo, Carolina Meloni Vicente, Luis Cesar de Azevedo, Maria Aparecida da Silva Pinhal, Leny Toma, Helena Bonciani Nader. Matrix Pathobiology and Angiogenesis. Biology of Extracellular Matrix 2023; 12: 229 doi: 10.1007/978-3-031-19616-4_9
|
| 39 |
Biagio Ricciuti, Jennifer Foglietta, Rita Chiari, Amirhossein Sahebkar, Maciej Banach, Vanessa Bianconi, Matteo Pirro. Emerging enzymatic targets controlling angiogenesis in cancer: preclinical evidence and potential clinical applications. Medical Oncology 2018; 35(1) doi: 10.1007/s12032-017-1064-5
|
| 40 |
Junyu Wu, Yau‐Tuen Chan, Yuanjun Lu, Ning Wang, Yibin Feng. The tumor microenvironment in the postsurgical liver: Mechanisms and potential targets of postoperative recurrence in human hepatocellular carcinoma. Medicinal Research Reviews 2023; 43(6): 1946 doi: 10.1002/med.21967
|
| 41 |
|
| 42 |
Nitin Ohri, Andreas Kaubisch, Madhur Garg, Chandan Guha. Targeted Therapy for Hepatocellular Carcinoma. Seminars in Radiation Oncology 2016; 26(4): 338 doi: 10.1016/j.semradonc.2016.06.004
|
| 43 |
Stefano Elli, Eduardo Stancanelli, Paul N Handley, Anthony Carroll, Elena Urso, Marco Guerrini, Vito Ferro. Structural and conformational studies of the heparan sulfate mimetic PI-88. Glycobiology 2018; 28(10): 731 doi: 10.1093/glycob/cwy068
|
| 44 |
Yiyuan Yang, Fengyan Yuan, Huiqin Zhou, Jing Quan, Chongyang Liu, Yi Wang, Fen Xiao, Qiao Liu, Jie Liu, Yujing Zhang, Xing Yu. Potential roles of heparanase in cancer therapy: Current trends and future direction. Journal of Cellular Physiology 2023; 238(5): 896 doi: 10.1002/jcp.30995
|
| 45 |
Benjamin Heyman, Yiping Yang. Mechanisms of heparanase inhibitors in cancer therapy. Experimental Hematology 2016; 44(11): 1002 doi: 10.1016/j.exphem.2016.08.006
|
| 46 |
Safa Kinaneh, Walaa Hijaze, Lana Mansour-Wattad, Rawan Hammoud, Hisam Zaidani, Aviva Kabala, Shadi Hamoud. Heparanase Inhibition Prevents Liver Steatosis in E0 Mice. Journal of Clinical Medicine 2022; 11(6): 1672 doi: 10.3390/jcm11061672
|
| 47 |
Yona Nadir, Benjamin Brenner. Novel strategies of coagulation inhibition for reducing tumor growth and angiogenesis. Thrombosis Research 2018; 164: S153 doi: 10.1016/j.thromres.2017.12.011
|
| 48 |
Shengjin Yu, Huiming Lv, Jinhui Zhang, He Zhang, Weiwei Ju, Yu Jiang, Lijuan Lin. Heparanase/Syndecan-1 Axis Regulates the Grade of Liver Cancer and Proliferative Ability of Hepatocellular Carcinoma Cells. Oncologie 2022; 24(3): 539 doi: 10.32604/oncologie.2022.024882
|
| 49 |
Valentina Masola, Gianluigi Zaza, Maurizio Onisto, Antonio Lupo, Giovanni Gambaro. Impact of heparanase on renal fibrosis. Journal of Translational Medicine 2015; 13(1) doi: 10.1186/s12967-015-0538-5
|
| 50 |
Israel Vlodavsky, Preeti Singh, Ilanit Boyango, Lilach Gutter-Kapon, Michael Elkin, Ralph D. Sanderson, Neta Ilan. Heparanase: From basic research to therapeutic applications in cancer and inflammation. Drug Resistance Updates 2016; 29: 54 doi: 10.1016/j.drup.2016.10.001
|
| 51 |
Wei Zhang, Bixiang Zhang, Xiao-ping Chen. Adjuvant treatment strategy after curative resection for hepatocellular carcinoma. Frontiers of Medicine 2021; 15(2): 155 doi: 10.1007/s11684-021-0848-3
|